mammary epithelial cell line
Cancer Research/Cell Biology
Lonza Optimized Protocol
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols
or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our
to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis
Farago M, Dominguez I, Landesman-Bollag E, Xu X, Rosner A, Cardiff RD and Seldin DC
Cancer Res (2005) 65(13): 5792-5801
©2023 Lonza. All rights reserved.